RAS inhibitors
CN115894606BActive Publication Date: 2026-10-16REVOLUTION MEDICINES INC
264 Cites 0 Cited by
Patent Information
- Application Number
- CN202211377108.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-06-24
- Filing Date
- 2020-11-04
- Publication Date
- 2026-10-16
- Estimated Expiration
- 2040-11-04
AI Technical Summary
Technical Problem
[0006]尽管在过去数十年中，针对Ras进行了广泛的药物发现工作，但直接靶向Ras的药物仍未得到批准
✦ Generated by Eureka AI based on patent content.
Abstract
The present disclosure provides macrocyclic compounds capable of inhibiting Ras proteins and pharmaceutical compositions and protein complexes thereof, and their use in the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art